New multiple sclerosis drug near patients
293341
Biogen Idec Inc.&#39;s Tysabri drug for multiple sclerosis may reach patients as soon as next week, and doctors said they plan to prescribe it first to patients who are no longer being helped by older medicines.
128455
MONDAY, Nov. 8 (HealthDayNews) -- Memory problems that prevent multiple sclerosis sufferers from doing their jobs are extremely troublesome and disheartening, say doctors, but a drug geared for Alzheimer's patients may offer some help.
261321
ELEANOR HALL: It&#39;s been found to help ameliorate some of the side-effects of chemotherapy, reduce spasms associated with multiple sclerosis and help patients with chronic pain.
533255
A drug used to treat Alzheimer&#39;s may also ease memory problems for people with multiple sclerosis, a disease of the brain and spinal cord, according to a study out today.
138698
Another schizophrenia drug from the company shows promise in a clinical trial.
259812
The pharmaceutical enlists help to thwart a troublesome illness.
176876
Drugs given to patients with multiple sclerosis can reduce brain tissue loss and slow down the progression of the illness, scientists said on Friday.
65239
Breakthrough treatments for multiple sclerosis (MS) may be just five years away, an Australian leader in stem cell research said in Christchurch yesterday.
495033
NEW YORK  - Early and ongoing treatment with interferon beta-1a can provide lasting benefits to patients with relapsing-remitting multiple sclerosis (MS), according to a report in the journal Neurology.
279186
WASHINGTON The first new cancer drug in ten years that is specifically designed to help children is a step closer to approval. An advisory panel at the Food and Drug Administration is recommending the use
271543
The Food and Drug Administration strongly endorsed Biogen Idec Inc.'s new multiple sclerosis treatment, putting the Cambridge firm in position to expand the market for MS drugs and win greater market share. The drug, formerly called Antegren but renamed Tysabri, was developed with Elan Pharmaceuticals of Ireland. The FDA approved Tysabri for use on its own and in ...
593038
Clinical trial results show significant   benefits for patients with relapsing multiple sclerosis treated   with Novartis's experimental FTY720 medicine, the company said   late on Wednesday.
287736
TORONTO - A new but potentially costly treatment for multiple sclerosis has received fast-track approval from the US Food and Drug Administration.
81887
Thousands of intensive care patients are set to benefit from a drug which has been recommended to NHS doctors.
41436
(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:
553739
Multiple Sclerosis drugs can reduce brain tissue loss and slow down the progression of the illness. That&#39;s according to a team of researchers from Italy.
472960
NEW YORK  - Boosting concentrations in the   nervous system of a vital compound called NAD, by giving its   chemical precursor, nicotinamide, a form of vitamin B3, has   shown considerable therapeutic potential in a mouse model of   multiple sclerosis (MS).